市場調查報告書
商品編碼
1029121

全球止血劑市場:行業趨勢、份額、市場規模、增長率、機會、預測(2021-2026)

Hemostats Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

出版日期: | 出版商: IMARC Services Private Limited | 英文 145 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

預計 2020 年全球止血劑市場規模將達到 31.3 億美元,並在 2021 年至 2026 年間以 6.2% 的複合年增長率增長。

由於慢性病、剖腹產、致命傷害和主要器官手術的患病率顯著增加,對止血劑的需求正在增加。止血劑也迅速受到醫療保健專業人員的歡迎,因為它們可以降低手術成本。除了這些發展之外,改進的醫療設施和廣泛的研發活動(R&D)以推出新產品正在對該行業產生積極影響。

本報告調查了全球止血劑市場、COVID-19 的市場概況/性能/影響、按產品/用途/處方/地區劃分的市場分析、競爭形勢、主要公司概況等。

目錄

第一章前言

第二章範圍和調查方法

第 3 章執行摘要

第 4 章介紹

第 5 章全球止血劑市場

  • 市場概覽
  • 市場表現
  • COVID-19 的影響

第 6 章市場細分:按產品

  • 凝血□基礎
  • 組合基礎
  • 氧化再生纖維素基質
  • 明膠基質
  • 膠原蛋白基礎

第 7 章市場細分:按應用

  • 骨科
  • 普通外科
  • 神經外科
  • 心血管外科
  • 重建手術
  • 婦科手術
  • 其他

第 8 章市場細分:按處方

  • 基質凝膠止血劑
  • 片墊止血劑
  • 海綿止血劑
  • 粉末止血劑

第 9 章市場細分:按地區

  • 北美
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳大利亞
    • 印度尼西亞
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 意大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東/非洲
    • 按國家/地區劃分的市場細分

第 10 章 SWOT 分析

第11章價值鏈分析

第十二章波特五力分析

第十三章價格分析

第14章競爭形勢

  • 市場結構
  • 主要公司
  • 主要公司簡介
    • Arch Therapeutics Inc.
    • Baxter International Inc.
    • B. Braun Melsungen Aktiengesell
    • C. R. Bard Inc. (BD)
    • GELITA MEDICAL GmbH
    • Integra LifeSciences Corporation
    • Johnson & Johnson
    • Pfizer Inc.
    • Stryker Corporation
    • Teleflex Incorporated
    • Z-Medica LLC
目錄
Product Code: SR1020F71_Report

The global hemostats market reached a value of US$ 3.13 Billion in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 6.2% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Hemostats are used to compress blood vessels and prevent the flow of blood or other fluids. They are generally used in adjunct to surgical procedures to manage bleeding. Hemostatic agents offer various benefits, including decreased wound healing and operative time, better management of anticoagulated patients, and reduction in the patient recovery period. A wide range of surgical hemostatic agents is available in the market that vary widely in their composition, cost, immunogenicity, mechanism of action, application and adherence.

On account of the significant rise in the prevalence of chronic disorders, cesarean deliveries, fatal injuries and major organ surgeries, there has been an increasing demand for hemostats. These agents help prevent blood loss during surgical procedures, particularly for nonanatomic and sensitive structures, and among patients with hemostatic abnormalities. Besides this, their use helps in lowering the cost of the procedure, which has led to their rapid adoption among healthcare providers. Moreover, with technological advancements, leading manufacturers have developed absorbable adjunctive hemostats that help professionals to control disruptive bleeding more efficiently as compared to traditional methods. Additionally, they are utilizing nano- and micro-materials for treating uncontrolled hemorrhage and internal bleeding. Market players have also introduced advanced laparoscopic hemostats designed to enhance the quality of surgical operations and allow for less invasive procedures. Along with these developments, improvements in healthcare facilities and extensive research and development (R&D) activities to launch new products, are providing a positive impact on the industry.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global hemostats market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on product, application and formulation.

Breakup by Product:

  • Thrombin Based
  • Combination Based
  • Oxidized Regenerated Cellulose Based
  • Gelatin Based
  • Collagen Based

Breakup by Application:

  • Orthopedic Surgery
  • General Surgery
  • Neurological Surgery
  • Cardiovascular Surgery
  • Reconstructive Surgery
  • Gynecological Surgery
  • Others

Breakup by Formulation:

  • Matrix and Gel Hemostats
  • Sheet and Pad Hemostats
  • Sponge Hemostats
  • Powder Hemostats

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Arch Therapeutics Inc., Baxter International Inc., B. Braun Melsungen Aktiengesell, C. R. Bard Inc., GELITA MEDICAL GmbH, Integra LifeSciences Corporation, Johnson & Johnson, Pfizer Inc., Stryker Corporation, Teleflex Incorporated and Z-Medica LLC. Key Questions Answered in This Report:

  • How has the global hemostats market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global hemostats market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the formulation?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global hemostats market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Hemostats Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Thrombin Based
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Combination Based
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Oxidized Regenerated Cellulose Based
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Gelatin Based
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Collagen Based
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Orthopedic Surgery
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 General Surgery
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Neurological Surgery
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Cardiovascular Surgery
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Reconstructive Surgery
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Gynecological Surgery
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Others
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast

8 Market Breakup by Formulation

  • 8.1 Matrix and Gel Hemostats
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Sheet and Pad Hemostats
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Sponge Hemostats
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Powder Hemostats
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Arch Therapeutics Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Baxter International Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 B. Braun Melsungen Aktiengesell
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 C. R. Bard Inc. (BD)
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 GELITA MEDICAL GmbH
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Integra LifeSciences Corporation
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Johnson & Johnson
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Pfizer Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Stryker Corporation
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Teleflex Incorporated
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Z-Medica LLC
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio

List of Figures

  • Figure 1: Global: Hemostats Market: Major Drivers and Challenges
  • Figure 2: Global: Hemostats Market: Sales Value (in Billion US$), 2015-2020
  • Figure 3: Global: Hemostats Market: Breakup by Product (in %), 2020
  • Figure 4: Global: Hemostats Market: Breakup by Application (in %), 2020
  • Figure 5: Global: Hemostats Market: Breakup by Formulation (in %), 2020
  • Figure 6: Global: Hemostats Market: Breakup by Region (in %), 2020
  • Figure 7: Global: Hemostats Market Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 8: Global: Hemostats Market (Thrombin Based): Sales Value (in Million US$), 2015 & 2020
  • Figure 9: Global: Hemostats Market Forecast (Thrombin Based): Sales Value (in Million US$), 2021-2026
  • Figure 10: Global: Hemostats Market (Combination Based): Sales Value (in Million US$), 2015 & 2020
  • Figure 11: Global: Hemostats Market Forecast (Combination Based): Sales Value (in Million US$), 2021-2026
  • Figure 12: Global: Hemostats Market (Oxidized Regenerated Cellulose Based): Sales Value (in Million US$), 2015 & 2020
  • Figure 13: Global: Hemostats Market Forecast (Oxidized Regenerated Cellulose Based): Sales Value (in Million US$), 2021-2026
  • Figure 14: Global: Hemostats Market (Gelatin Based): Sales Value (in Million US$), 2015 & 2020
  • Figure 15: Global: Hemostats Market Forecast (Gelatin Based): Sales Value (in Million US$), 2021-2026
  • Figure 16: Global: Hemostats Market (Collagen Based): Sales Value (in Million US$), 2015 & 2020
  • Figure 17: Global: Hemostats Market Forecast (Collagen Based): Sales Value (in Million US$), 2021-2026
  • Figure 18: Global: Hemostats Market (Orthopedic Surgery): Sales Value (in Million US$), 2015 & 2020
  • Figure 19: Global: Hemostats Market Forecast (Orthopedic Surgery): Sales Value (in Million US$), 2021-2026
  • Figure 20: Global: Hemostats Market (General Surgery): Sales Value (in Million US$), 2015 & 2020
  • Figure 21: Global: Hemostats Market Forecast (General Surgery): Sales Value (in Million US$), 2021-2026
  • Figure 22: Global: Hemostats Market (Neurological Surgery): Sales Value (in Million US$), 2015 & 2020
  • Figure 23: Global: Hemostats Market Forecast (Neurological Surgery): Sales Value (in Million US$), 2021-2026
  • Figure 24: Global: Hemostats Market (Cardiovascular Surgery): Sales Value (in Million US$), 2015 & 2020
  • Figure 25: Global: Hemostats Market Forecast (Cardiovascular Surgery): Sales Value (in Million US$), 2021-2026
  • Figure 26: Global: Hemostats Market (Reconstructive Surgery): Sales Value (in Million US$), 2015 & 2020
  • Figure 27: Global: Hemostats Market Forecast (Reconstructive Surgery): Sales Value (in Million US$), 2021-2026
  • Figure 28: Global: Hemostats Market (Gynecological Surgery): Sales Value (in Million US$), 2015 & 2020
  • Figure 29: Global: Hemostats Market Forecast (Gynecological Surgery): Sales Value (in Million US$), 2021-2026
  • Figure 30: Global: Hemostats Market (Other Applications): Sales Value (in Million US$), 2015 & 2020
  • Figure 31: Global: Hemostats Market Forecast (Other Applications): Sales Value (in Million US$), 2021-2026
  • Figure 32: Global: Hemostats Market (Matrix and Gel Hemostats): Sales Value (in Million US$), 2015 & 2020
  • Figure 33: Global: Hemostats Market Forecast (Matrix and Gel Hemostats): Sales Value (in Million US$), 2021-2026
  • Figure 34: Global: Hemostats Market (Sheet and Pad Hemostats): Sales Value (in Million US$), 2015 & 2020
  • Figure 35: Global: Hemostats Market Forecast (Sheet and Pad Hemostats): Sales Value (in Million US$), 2021-2026
  • Figure 36: Global: Hemostats Market (Sponge Hemostats): Sales Value (in Million US$), 2015 & 2020
  • Figure 37: Global: Hemostats Market Forecast (Sponge Hemostats): Sales Value (in Million US$), 2021-2026
  • Figure 38: Global: Hemostats Market (Powder Hemostats): Sales Value (in Million US$), 2015 & 2020
  • Figure 39: Global: Hemostats Market Forecast (Powder Hemostats): Sales Value (in Million US$), 2021-2026
  • Figure 40: North America: Hemostats Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 41: North America: Hemostats Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 42: United States: Hemostats Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 43: United States: Hemostats Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 44: Canada: Hemostats Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 45: Canada: Hemostats Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 46: Asia Pacific: Hemostats Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 47: Asia Pacific: Hemostats Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 48: China: Hemostats Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 49: China: Hemostats Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 50: Japan: Hemostats Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 51: Japan: Hemostats Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 52: India: Hemostats Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 53: India: Hemostats Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 54: South Korea: Hemostats Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 55: South Korea: Hemostats Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 56: Australia: Hemostats Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 57: Australia: Hemostats Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 58: Indonesia: Hemostats Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 59: Indonesia: Hemostats Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 60: Others: Hemostats Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 61: Others: Hemostats Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 62: Europe: Hemostats Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 63: Europe: Hemostats Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 64: Germany: Hemostats Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 65: Germany: Hemostats Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 66: France: Hemostats Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 67: France: Hemostats Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 68: United Kingdom: Hemostats Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 69: United Kingdom: Hemostats Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 70: Italy: Hemostats Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 71: Italy: Hemostats Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 72: Spain: Hemostats Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 73: Spain: Hemostats Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 74: Russia: Hemostats Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 75: Russia: Hemostats Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 76: Others: Hemostats Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 77: Others: Hemostats Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 78: Latin America: Hemostats Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 79: Latin America: Hemostats Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 80: Brazil: Hemostats Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 81: Brazil: Hemostats Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 82: Mexico: Hemostats Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 83: Mexico: Hemostats Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 84: Others: Hemostats Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 85: Others: Hemostats Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 86: Middle East and Africa: Hemostats Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 87: Middle East and Africa: Hemostats Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 88: Global: Hemostats Industry: SWOT Analysis
  • Figure 89: Global: Hemostats Industry: Value Chain Analysis
  • Figure 90: Global: Hemostats Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Hemostats Market: Key Industry Highlights, 2020 and 2026
  • Table 2: Global: Hemostats Market Forecast: Breakup by Product (in Million US$), 2021-2026
  • Table 3: Global: Hemostats Market Forecast: Breakup by Application (in Million US$), 2021-2026
  • Table 4: Global: Hemostats Market Forecast: Breakup by Formulation (in Million US$), 2021-2026
  • Table 5: Global: Hemostats Market Forecast: Breakup by Region (in Million US$), 2021-2026
  • Table 6: Global: Hemostats Market Structure
  • Table 7: Global: Hemostats Market: Key Players